Skip to content

Welcome to Discover Pharma! Today is : October 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Medical Imaging

  • Digital & Data,Drug Discovery & Development,Research & Development

    NVision deploys quantum-enhanced MRI platform at Hokkaido University

    NVision has deployed its POLARIS quantum-enhanced MRI platform at Hokkaido [...]

    September 14, 2026
  • Clinical & Regulatory,Medical devices,Research & Development,Therapeutic Areas

    MRI study suggests some prostate cancer biopsies could eventually be avoided

    A study of 880 men found clinically significant prostate cancer [...]

    August 26, 2026
  • Advanced Therapies,Clinical & Regulatory,Digital & Data,Research & Development,Therapeutic Areas

    Brainomix to present five ILD studies on quantitative CT at ERS Congress

    Brainomix will present five studies examining quantitative CT biomarkers in [...]

    August 25, 2026
  • Clinical & Regulatory,Digital & Data,Medical devices,Research & Development,Therapeutic Areas

    Oxford research to explore AI stroke prediction from routine cardiac CT at ESC 2026

    University of Oxford-led research will examine whether artificial intelligence can [...]

    August 24, 2026
  • Digital & Data

    Qureight expands London operations to develop AI chest imaging model

    Qureight has opened a second UK site in London as [...]

    August 19, 2026
  • Biotech & Pharma Business,Central Nervous System,Clinical & Regulatory,Digital & Data,Medical devices

    OSF HealthCare expands RapidAI clinical AI platform to all 18 hospitals

    OSF HealthCare is expanding its use of RapidAI’s clinical AI [...]

    August 12, 2026
  • Digital & Data,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    AI model cuts radiopharmaceutical dose mapping to seconds in prostate cancer study

    A new AI model has generated patient-specific radiation dose-rate maps [...]

    August 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development

    Qureight raises $20 million to expand AI imaging platform into new lung and heart diseases

    Qureight has raised $20 million in a Series B financing [...]

    July 30, 2026
  • Clinical & Regulatory,Digital & Data,Medical devices

    ThinkSono wins FDA clearance for AI-guided ultrasound software for suspected DVT

    ThinkSono has received US FDA 510(k) clearance for ThinkSono Guidance, [...]

    July 31, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development

    Qureight raises $20 million to expand AI imaging platform for clinical trials

    Qureight has raised $20 million in a Series B financing [...]

    July 29, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • BridgeBio gets FDA Priority Review for oral infigratinib in achondroplasia
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • ViiV’s Cabenuva achieves superior viral suppression in CROWN Phase 3b study
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Shift Bioscience publishes AI virtual cell framework for target discovery
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top